NCT01265875View on ClinicalTrials.gov

Secretin Infusion for Pain Due to Chronic Pancreatitis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2012

Conditions

Chronic Pancreatitis

Interventions

DRUG

Human Secretin

Dose Escalation

Trial Locations (1)

03756

Dartmouth Hitchcock Medical Center, Lebanon

Sponsors

Lead Sponsor

ChiRhoClin, Inc.

All Listed Sponsors

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

lead

ChiRhoClin, Inc.

INDUSTRY